期刊文献+

艾地苯醌对血小板生物学特性影响的初步研究

A Preliminary Study on the Effect of Idebenone on the Biological Characteristics of Platelets
下载PDF
导出
摘要 目的本研究拟通过艾地苯醌对血小板生物学特性的影响,以期探讨其在血小板保存方面的应用价值。方法体外实验中,富小板血浆加入终浓度为10μg/mL艾地苯醌作为实验组,检测血小板粘附和聚集功能,血浆丙二醛、还原型谷胱甘肽、以及血小板膜表面CD62p和线粒体膜电位的变化。结果与对照组相比,实验组血小板的粘附率和聚集率均有一定程度的下降(P<0.05);血浆丙二醛水平降低(P<0.05)而谷胱甘肽水平升高(P<0.05);CD62p的阳性率无显著性变化,但JC-1的阳性率有显著性增加(P<0.05)。结论10μg/mL艾地苯醌有利于血小板线粒体的代谢,但是对血小板的粘附和聚集功能产生一定的抑制作用。 Objective To explore the application value of idebenone in platelet preservation through its effect of on platelet biological characteristics.Methods In vitro experiment,platelet-rich plasma was added idebenone with the final concentration of 10μg/mL as the experimental group.We detected the platelet adhesion and aggregation function,plasma malondialdehyde(MDA)concentration,reduced glutathione(GSH)concentration,and CD62p expression on platelet membrane surface and JC-1 on mitochondrion surface.Results Compared with the control group,platelet adhesion and aggregation rate decreased to a certain extent(P<0.05);The MDA level decreased(P<0.05)while reduced GSH level increased(P<0.05);The positive rate of CD62p showed no significant change,but the positive rate of JC-1 increased significantly(P<0.05).Conclusion Idebenone would be beneficial to the metabolism of platelet mitochondria,but it has a certain inhibitory effect on platelet adhesion and aggregation with the concentration of 10μg/mL.
作者 林俊填 麦志周 杨富燕 伍伟健 刘运芝 余玉婷 LIN Jun-tian;MAI Zhi-zhou;YANG Fu-yan(Foshan Central Blood Station,528000)
出处 《临床输血与检验》 CAS 2021年第5期628-631,共4页 Journal of Clinical Transfusion and Laboratory Medicine
基金 广东省佛山市自筹经费类科技计划项目(No.1920001000780)资助。
关键词 艾地苯醌 血小板 粘附 聚集 CD62P Idebenone Platelet Adhesion Aggregation CD62p
  • 相关文献

参考文献10

二级参考文献62

  • 1楼伟伟,尤春景,许涛,张琰.计算机辅助认知训练对脑损伤患者认知功能与功能独立性的影响[J].中华物理医学与康复杂志,2007,29(7):462-465. 被引量:17
  • 2Tonon C,Lodi R.Idebenone in Friedreich's ataxia[J].Expert Opin Pharmacother,2008,9:2327-37. 被引量:1
  • 3Rustin P,von Kleist-Retzow JC,Chantrel-Groussard K,et al.Effect of idebenone on cardiomyopathy in friedreich's ataxia:a preliminary study[J].Lancet,1999,354,477-479. 被引量:1
  • 4Artuch R,Aracil.A,Mas A.et al.Friedreich's ataxia:Idebenone treatment in early stage patients[J].Neuropediatrics,2002,33:190-193. 被引量:1
  • 5Trouillas P,Takayanagi T,Hallett M,et al.International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome.The Ataxia Neuropharmacology Committee of the World Federation of Neurology[J].J Neurol Sci,1997,145:205-211. 被引量:1
  • 6Buyse G,Mertens L,Di Salvo G..et al.Idebenone treatment in friedreich's ataxia,neurological,cardiac,and biochemical monitoring High dose[J].Neurology 2003,60:1679-1681. 被引量:1
  • 7Sch(o)ls L,Vorgerd M,Schillings M,et al.Idebenone in patients with friedreich ataxia[J].Neurosci Lett,2001,306:169-172. 被引量:1
  • 8Di Prospero NA,Baker A,Jeffries N,et al.Neurological effects of high-dose idebenone in patients with Friedreich's ataxia:a randomised,placebo-controlled trial[J].Lancet Neurol 2007,6,878-886. 被引量:1
  • 9Pineda M,Arpa J,Montero R,et al.Idebenone treatment in paediatric and adult patients with Friedreich ataxia:long-term follow-up[J].Eur J Paediatr Neurol,2008,12:.470-475. 被引量:1
  • 10Arnold P,Boulat O,Maire R,et al.Expanding view of phenotype and oxidative stress in Friedreich's ataxia patients with and without idebenone[J].Schweizer Archiv f ü r Neurology und Psychiatry,2006,157:169-176. 被引量:1

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部